Edgestream Partners, L.P. Harmony Biosciences Holdings, Inc. Transaction History

Edgestream Partners, L.P.

  • $2.23 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$29.93 - $35.06 $339,286 - $397,440
11,336 Added 23.16%
60,281 $2.02 Million
Q4 2023

Feb 14, 2024
BUY
$19.2 - $33.78 $600,998 - $1.06 Million
31,302 Added 177.42%
48,945 $1.58 Million
Q3 2023

Nov 14, 2023
SELL
$31.89 - $39.03 $1 Million - $1.23 Million
-31,429 Reduced 64.05%
17,643 $578,000
Q2 2023

Aug 10, 2023
BUY
$30.5 - $37.4 $1.5 Million - $1.84 Million
49,072 New
49,072 $1.73 Million

Others Institutions Holding HRMY

# of Institutions
242
Shares Held
45.1M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Edgestream Partners, L.P. Portfolio

Follow Edgestream Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email